TWI695008B - An organic electroluminescent device containing tetradentate platinum (ii) complex - Google Patents
An organic electroluminescent device containing tetradentate platinum (ii) complex Download PDFInfo
- Publication number
- TWI695008B TWI695008B TW107147289A TW107147289A TWI695008B TW I695008 B TWI695008 B TW I695008B TW 107147289 A TW107147289 A TW 107147289A TW 107147289 A TW107147289 A TW 107147289A TW I695008 B TWI695008 B TW I695008B
- Authority
- TW
- Taiwan
- Prior art keywords
- complex
- atoms
- halogen
- substituted
- electroluminescent device
- Prior art date
Links
- HRGDZIGMBDGFTC-UHFFFAOYSA-N platinum(2+) Chemical compound [Pt+2] HRGDZIGMBDGFTC-UHFFFAOYSA-N 0.000 title claims abstract description 31
- 239000010410 layer Substances 0.000 claims abstract description 20
- 239000000463 material Substances 0.000 claims abstract description 14
- 239000012044 organic layer Substances 0.000 claims abstract description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 35
- 229910052736 halogen Inorganic materials 0.000 claims description 28
- 150000002367 halogens Chemical class 0.000 claims description 27
- 125000003118 aryl group Chemical group 0.000 claims description 25
- 125000000217 alkyl group Chemical group 0.000 claims description 24
- 125000001072 heteroaryl group Chemical group 0.000 claims description 16
- 229910052739 hydrogen Inorganic materials 0.000 claims description 10
- 239000001257 hydrogen Substances 0.000 claims description 10
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 9
- -1 amino, nitro, acetylamino Chemical group 0.000 claims description 9
- 229910052801 chlorine Inorganic materials 0.000 claims description 8
- 229910052731 fluorine Inorganic materials 0.000 claims description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- 125000004986 diarylamino group Chemical group 0.000 claims description 6
- 229910052794 bromium Inorganic materials 0.000 claims description 5
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 5
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
- 238000002207 thermal evaporation Methods 0.000 claims description 3
- 125000004417 unsaturated alkyl group Chemical group 0.000 claims description 3
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 125000004104 aryloxy group Chemical group 0.000 claims description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 2
- 229910052805 deuterium Inorganic materials 0.000 claims description 2
- 238000007641 inkjet printing Methods 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 238000004528 spin coating Methods 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 2
- QGMGHALXLXKCBD-UHFFFAOYSA-N 4-amino-n-(2-aminophenyl)benzamide Chemical compound C1=CC(N)=CC=C1C(=O)NC1=CC=CC=C1N QGMGHALXLXKCBD-UHFFFAOYSA-N 0.000 claims 1
- 239000004202 carbamide Substances 0.000 claims 1
- 235000013877 carbamide Nutrition 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 125000005504 styryl group Chemical group 0.000 claims 1
- 239000002019 doping agent Substances 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 238000010791 quenching Methods 0.000 abstract description 2
- 230000000171 quenching effect Effects 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 75
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 49
- 229910052757 nitrogen Inorganic materials 0.000 description 29
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 24
- 239000007787 solid Substances 0.000 description 24
- 239000002904 solvent Substances 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 18
- 150000001875 compounds Chemical class 0.000 description 14
- 239000012074 organic phase Substances 0.000 description 14
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 13
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 13
- 230000015572 biosynthetic process Effects 0.000 description 13
- 238000004440 column chromatography Methods 0.000 description 13
- 238000000605 extraction Methods 0.000 description 13
- 239000000741 silica gel Substances 0.000 description 13
- 229910002027 silica gel Inorganic materials 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 12
- 238000003786 synthesis reaction Methods 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 229910000027 potassium carbonate Inorganic materials 0.000 description 9
- 125000001424 substituent group Chemical group 0.000 description 9
- 239000000460 chlorine Substances 0.000 description 8
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 8
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- AUALQMFGWLZREY-UHFFFAOYSA-N acetonitrile;methanol Chemical compound OC.CC#N AUALQMFGWLZREY-UHFFFAOYSA-N 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 4
- 125000003342 alkenyl group Chemical group 0.000 description 4
- 238000001819 mass spectrum Methods 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- IVDFJHOHABJVEH-UHFFFAOYSA-N pinacol Chemical compound CC(C)(O)C(C)(C)O IVDFJHOHABJVEH-UHFFFAOYSA-N 0.000 description 4
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 4
- IMRWILPUOVGIMU-UHFFFAOYSA-N 2-bromopyridine Chemical compound BrC1=CC=CC=N1 IMRWILPUOVGIMU-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 101000687716 Drosophila melanogaster SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 homolog Proteins 0.000 description 3
- 101000687741 Mus musculus SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 Proteins 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 3
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 3
- 229940125898 compound 5 Drugs 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 238000002390 rotary evaporation Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 2
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 2
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 2
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 2
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 2
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 2
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 2
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 2
- BMIBJCFFZPYJHF-UHFFFAOYSA-N 2-methoxy-5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine Chemical compound COC1=NC=C(C)C=C1B1OC(C)(C)C(C)(C)O1 BMIBJCFFZPYJHF-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 238000006069 Suzuki reaction reaction Methods 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- 125000004062 acenaphthenyl group Chemical group C1(CC2=CC=CC3=CC=CC1=C23)* 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 150000001716 carbazoles Chemical class 0.000 description 2
- 229940126543 compound 14 Drugs 0.000 description 2
- 229940125758 compound 15 Drugs 0.000 description 2
- 229940126142 compound 16 Drugs 0.000 description 2
- 229940126214 compound 3 Drugs 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 230000005525 hole transport Effects 0.000 description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 2
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 239000013212 metal-organic material Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 150000003222 pyridines Chemical class 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- ROEQGIFOWRQYHD-UHFFFAOYSA-N (2-methoxyphenyl)boronic acid Chemical compound COC1=CC=CC=C1B(O)O ROEQGIFOWRQYHD-UHFFFAOYSA-N 0.000 description 1
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 description 1
- UVNPEUJXKZFWSJ-LMTQTHQJSA-N (R)-N-[(4S)-8-[6-amino-5-[(3,3-difluoro-2-oxo-1H-pyrrolo[2,3-b]pyridin-4-yl)sulfanyl]pyrazin-2-yl]-2-oxa-8-azaspiro[4.5]decan-4-yl]-2-methylpropane-2-sulfinamide Chemical compound CC(C)(C)[S@@](=O)N[C@@H]1COCC11CCN(CC1)c1cnc(Sc2ccnc3NC(=O)C(F)(F)c23)c(N)n1 UVNPEUJXKZFWSJ-LMTQTHQJSA-N 0.000 description 1
- UGUHFDPGDQDVGX-UHFFFAOYSA-N 1,2,3-thiadiazole Chemical compound C1=CSN=N1 UGUHFDPGDQDVGX-UHFFFAOYSA-N 0.000 description 1
- YGTAZGSLCXNBQL-UHFFFAOYSA-N 1,2,4-thiadiazole Chemical compound C=1N=CSN=1 YGTAZGSLCXNBQL-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- FEYDZHNIIMENOB-UHFFFAOYSA-N 2,6-dibromopyridine Chemical compound BrC1=CC=CC(Br)=N1 FEYDZHNIIMENOB-UHFFFAOYSA-N 0.000 description 1
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- WDBQJSCPCGTAFG-QHCPKHFHSA-N 4,4-difluoro-N-[(1S)-3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-pyridin-3-ylpropyl]cyclohexane-1-carboxamide Chemical compound FC1(CCC(CC1)C(=O)N[C@@H](CCN1CCC(CC1)N1C(=NN=C1C)C(C)C)C=1C=NC=CC=1)F WDBQJSCPCGTAFG-QHCPKHFHSA-N 0.000 description 1
- BWGRDBSNKQABCB-UHFFFAOYSA-N 4,4-difluoro-N-[3-[3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-thiophen-2-ylpropyl]cyclohexane-1-carboxamide Chemical compound CC(C)C1=NN=C(C)N1C1CC2CCC(C1)N2CCC(NC(=O)C1CCC(F)(F)CC1)C1=CC=CS1 BWGRDBSNKQABCB-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229910052693 Europium Inorganic materials 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- NUGPIZCTELGDOS-QHCPKHFHSA-N N-[(1S)-3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-pyridin-3-ylpropyl]cyclopentanecarboxamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CC[C@@H](C=1C=NC=CC=1)NC(=O)C1CCCC1)C NUGPIZCTELGDOS-QHCPKHFHSA-N 0.000 description 1
- LFZAGIJXANFPFN-UHFFFAOYSA-N N-[3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-thiophen-2-ylpropyl]acetamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CCC(C=1SC=CC=1)NC(C)=O)C LFZAGIJXANFPFN-UHFFFAOYSA-N 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- CXADQLLYLMBGTG-UHFFFAOYSA-N acetonitrile;1,4-dioxane Chemical compound CC#N.C1COCCO1 CXADQLLYLMBGTG-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 1
- 125000006620 amino-(C1-C6) alkyl group Chemical group 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- WCZVZNOTHYJIEI-UHFFFAOYSA-N cinnoline Chemical compound N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000003810 ethyl acetate extraction Methods 0.000 description 1
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 150000002240 furans Chemical class 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000001828 phenalenyl group Chemical group C1(C=CC2=CC=CC3=CC=CC1=C23)* 0.000 description 1
- LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical compound C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- NBRKLOOSMBRFMH-UHFFFAOYSA-N tert-butyl chloride Chemical compound CC(C)(C)Cl NBRKLOOSMBRFMH-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
- H10K50/12—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers comprising dopants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/02—Use of particular materials as binders, particle coatings or suspension media therefor
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/30—Coordination compounds
- H10K85/341—Transition metal complexes, e.g. Ru(II)polypyridine complexes
- H10K85/346—Transition metal complexes, e.g. Ru(II)polypyridine complexes comprising platinum
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/18—Metal complexes
- C09K2211/185—Metal complexes of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Electroluminescent Light Sources (AREA)
Abstract
Description
本發明涉及一種含新型N^N^N^O四齒鉑(II)配合物金屬有機材料的OLED發光器件。 The invention relates to an OLED light-emitting device containing a novel N^N^N^O tetradentate platinum (II) complex metal organic material.
有機發光二極體(OLED,Organic Light-Emitting Diode)顯示技術自發現以來,因其具有能耗低、視角大、可柔性化等獨特的性能一直受到廣泛的關注與研究,近些年來更是在手機、電視、筆記型電腦等電子產品上逐步應用。但是與傳統的顯示技術相比,OLED存在使用壽命短、色彩純度差、易老化等缺點導致其成本居高不下,阻礙了OLED技術的推廣與發展。因此,如何設計新型的OLED材料,則是OLED領域研究的重點與難點。 Since its discovery, Organic Light-Emitting Diode (OLED) display technology has been widely concerned and researched for its unique properties such as low energy consumption, large viewing angle, and flexibility, especially in recent years. It is gradually applied to electronic products such as mobile phones, televisions, and notebook computers. However, compared with traditional display technology, OLED has shortcomings such as short service life, poor color purity, and easy aging. Its cost remains high, which hinders the promotion and development of OLED technology. Therefore, how to design new OLED materials is the focus and difficulty of OLED research.
在OLED材料領域,磷光OLED材料發展較為迅速與成熟。磷光OLED材料主要是基於一些重金屬有機配合物,如銥、鉑、銪、鋨等。磷光材料在發光過程中可以充分利用單線態和三線態激子的能量,因此理論上其量子效率可達到100%,這大大提高了OLED器件的發光效率,是目前業界使用比較廣的發光材料。 In the field of OLED materials, the development of phosphorescent OLED materials is relatively rapid and mature. Phosphorescent OLED materials are mainly based on some heavy metal organic complexes, such as iridium, platinum, europium, osmium, etc. Phosphorescent materials can make full use of the energy of singlet and triplet excitons in the light-emitting process, so theoretically their quantum efficiency can reach 100%, which greatly improves the luminous efficiency of OLED devices and is currently widely used in the industry.
其中,近些年來基於鉑(II)的磷光OLED材料在逐步發展並取得了較好的研究成果。鉑(II)一般為四配位點,因而可以通過設計四齒配體形成具有
唯一構型的金屬有機鉑(II)配合物。一般而言,常見的四齒配體主要有O^N^N^O(如式(1)),O^N^C^O(如式(2))類型,
其中,O^N^N^O類四齒鉑(II)配合物主要為席夫堿(Schiff base)類,較為常見,但穩定性相對較差;O^N^C^O類四齒鉑(II)配合物相對較為穩定,但性能有待提升。 Among them, O^N^N^O-type tetradentate platinum (II) complexes are mainly Schiff bases, which are more common, but the stability is relatively poor; O^N^C^O-type tetradentate platinum ( II) The complex is relatively stable, but its performance needs to be improved.
針對上述領域的缺陷,本發明一種含四齒鉑(II)配合物的有機電致發光器件,發光性能好,同時具有較好的穩定性。 In view of the defects in the above-mentioned fields, the present invention provides an organic electroluminescent device containing a tetradentate platinum (II) complex, which has good luminous performance and good stability.
一種含四齒鉑(II)配合物的有機電致發光器件,包括陽極,陰極和中間有機層,所述有機層中至少包括有發光層,其中發光層中含有式(3)所示結構的四齒鉑(II)配合物作為磷光摻雜材料,
其中,A1-A5為取代的或非取代的五元環、六元環、稠環結構。 Among them, A1-A5 is a substituted or unsubstituted five-membered ring, six-membered ring, or fused ring structure.
優選:如式(4)所示的結構:
其中R1-R17獨立的選自氫、氘、鹵素、羥基、醯基、烷氧基、醯氧基、氨基、硝基、醯基氨基、氰基、羧基、苯乙烯基、氨基羰基、氨基甲醯基、苄基羰基、芳氧基、二芳胺基、含1-30個C原子的飽和烷基、含1-20個C原子的不飽和烷基、含6-30個C原子取代的或未取代的芳基、含5-30個C原子取代的或未取代的雜芳基、或者相鄰R1-R17相互通過共價鍵連接成環;其中,X1-X27為碳,所述鹵素為F,Cl,Br。 Wherein R 1 -R 17 are independently selected from hydrogen, deuterium, halogen, hydroxy, acetyl, alkoxy, acetyl, amino, nitro, acetylamino, cyano, carboxy, styrenyl, aminocarbonyl, Carbamate, benzylcarbonyl, aryloxy, diarylamino, saturated alkyl containing 1-30 C atoms, unsaturated alkyl containing 1-20 C atoms, containing 6-30 C atoms Substituted or unsubstituted aryl groups, substituted or unsubstituted heteroaryl groups containing 5-30 C atoms, or adjacent R 1 -R 17 are connected to each other through a covalent bond to form a ring; wherein, X 1 -X 27 Is carbon, the halogen is F, Cl, Br.
優選:其中R1-R17獨立的選自氫、鹵素、氨基、硝基、氰基、二芳胺基、含1-10個C原子的飽和烷基、含6-20個C原子的被鹵素或一個或多個C1-C4烷基取代的或未取代芳基、含5-20個C原子的被鹵素或一個或多個C1- C4烷基取代的或未取代雜芳基、或者相鄰R1-R17相互通過共價鍵連接成環,所述鹵素為F,Cl。 Preferably: wherein R 1 -R 17 are independently selected from the group consisting of hydrogen, halogen, amino, nitro, cyano, diarylamino, saturated alkyl containing 1-10 C atoms, coatings containing 6-20 C atoms Halogen or one or more C1-C4 alkyl substituted or unsubstituted aryl groups, 5-20 C atoms substituted or halogen or one or more C1-C4 alkyl substituted or unsubstituted heteroaryl groups, or phase The o-R 1 -R 17 are connected to each other through a covalent bond to form a ring, and the halogen is F, Cl.
優選:為下列結構
其中R1’-R5’獨立的選自氫、鹵素、二芳胺基、含1-10個C原子的飽和烷基、含6-10個C原子的被鹵素或一個或多個C1-C4烷基取代的或未取代芳基、含5-10個C原子的被鹵素或一個或多個C1-C4烷基取代的或未取代雜芳基、或者相鄰R1-R17相互通過共價鍵連接成環。 Wherein R 1 '-R 5' are independently selected from hydrogen, halogen, di-arylamino, saturated alkyl group containing 1-10 C atoms, having 6-10 C atoms or one or more halogen C1- C4 alkyl substituted or unsubstituted aryl, 5-10 C atoms substituted or unsubstituted heteroaryl substituted by halogen or one or more C1-C4 alkyl, or adjacent R 1 -R 17 pass each other Covalent bonds are connected to form a ring.
優選:R1’-R5’的5個基團中,其中有0-3個基團獨立的表示為二芳胺基、含6-10個C原子被鹵素或一至三個C1-C4烷基取代的或未取代的芳基、含5-10個C原子的被鹵素或一至三個C1-C4烷基取代的或未取代的雜芳基;其它的基團獨立的表示為氫或含1-8個C原子的飽和烷基,所述鹵素為F。 Preferably: R 1 '-R 5' 5 groups, wherein there are 0-3 groups independently represent a diarylamino group containing 6-10 C atoms or by one to three halogen, C1-C4 alkoxy Aryl substituted or unsubstituted, heteroaryl containing 5-10 C atoms substituted with halogen or one to three C1-C4 alkyl or unsubstituted heteroaryl; other groups are independently indicated as hydrogen or containing Saturated alkyl group with 1-8 C atoms, the halogen is F.
優選:R1’-R5’的5個基團中,其中有0-3個基團獨立的表示為二苯胺基、苯、吡啶、咔唑基,其它基團獨立的表示為氫、異丙基或叔丁基。 Preferably: R 1 '-R 5' 5 groups, wherein there are 0-3 groups independently represent as diphenylamino, phenyl, pyridyl, carbazolyl, other groups independently represent hydrogen, iso Propyl or tert-butyl.
為了本申請的目的,除非另有指明,術語鹵素、烷基、烯基、芳基、醯基、烷氧基和雜環芳族體系或雜環芳族基團可有以下含義:上述鹵素或鹵代包括氟、氯、溴和碘,優選F,Cl,Br,特別優選F或Cl,最優選F。 For the purposes of this application, unless otherwise indicated, the terms halogen, alkyl, alkenyl, aryl, acetyl, alkoxy, and heterocyclic aromatic systems or heterocyclic aromatic groups may have the following meanings: halogen or Halo includes fluorine, chlorine, bromine and iodine, preferably F, Cl, Br, particularly preferably F or Cl, most preferably F.
上述通過共價鍵連接成環、芳基、雜芳基包括具有6-30個碳原子,優選6-20個碳原子,更優選6-10個碳原子並且由一個芳環或多個稠和的芳環組成的芳基。適宜的芳基為,例如苯基,萘基,苊基(acenaphthenyl),二氫苊基(acenaphthenyl),蒽基、芴基、菲基(phenalenyl)。該芳基可為未取代的(即所有能夠取代的碳原子帶有氫原子)或在芳基的一個、多於一個或所有可取代的位置上被取代。適宜的取代基為例如鹵素,優選F、Br或Cl;烷基,優選具有1-20個,1-10個或1-8個碳原子的烷基,特別優選甲基、乙基、異丙基或叔丁基;芳基,優選可再次被取代的或是未取代C5,C6芳基或芴基;雜芳基,優選含至少一個氮原子的雜芳基,特別優選吡啶基;芳基尤其特別優選帶有選自F和叔丁基的取代基,優選可為給定的芳基或任選被至少一個上述取代基取代的為C5,C6芳基的芳基,C5,C6芳基特別優選帶有0、1或2個上述取代基,C5,C6芳基尤其特別優選未取代的苯基或取代的苯基,諸如聯苯基、被兩個叔丁基優選在間位取代的苯基。 The above-mentioned ring, aryl, and heteroaryl groups connected by a covalent bond include 6-30 carbon atoms, preferably 6-20 carbon atoms, more preferably 6-10 carbon atoms, and are fused by one aromatic ring or multiple Aryl group consisting of aromatic rings. Suitable aryl groups are, for example, phenyl, naphthyl, acenaphthenyl, acenaphthenyl, anthracenyl, fluorenyl, phenalenyl. The aryl group may be unsubstituted (ie, all carbon atoms that can be substituted carry hydrogen atoms) or substituted at one, more than one, or all substitutable positions of the aryl group. Suitable substituents are, for example, halogen, preferably F, Br or Cl; alkyl, preferably alkyl having 1-20, 1-10 or 1-8 carbon atoms, particularly preferably methyl, ethyl, isopropyl Group or tert-butyl group; aryl group, preferably re-substituted or unsubstituted C 5 , C 6 aryl group or fluorenyl group; heteroaryl group, preferably a heteroaryl group containing at least one nitrogen atom, particularly preferably pyridyl; The aryl group particularly particularly preferably carries a substituent selected from F and tert-butyl, preferably an aryl group which may be a given aryl group or optionally substituted by at least one of the above substituents is a C 5 , C 6 aryl group, C 5 , C 6 aryl group particularly preferably carries 0, 1 or 2 of the above substituents, C 5 , C 6 aryl group is particularly preferably unsubstituted phenyl or substituted phenyl, such as biphenyl, by two tertiary The butyl group is preferably a phenyl group substituted in the meta position.
含1-20個C原子的不飽和烷基,優選烯基,更優選具有一個雙鍵的烯基,特別優選具有雙鍵和1-8個碳原子的烯基。 The unsaturated alkyl group having 1 to 20 C atoms is preferably an alkenyl group, more preferably an alkenyl group having a double bond, and particularly preferably an alkenyl group having a double bond and 1 to 8 carbon atoms.
上述烷基包括具有1-30個碳原子,優選1-10個碳原子,優選1-4個碳原子的烷基。該烷基可為支鏈或直鏈的,也可以是環形的,並且可被一個或多個雜原子,優選N、O或S間斷。而且,該烷基可被一個或多個鹵素或上述的關於芳基的取代基所取代。同樣,對於烷基而言,帶有一個或多個芳基是可能的,所有上述的芳基均適用於該目的,烷基特別優選自甲基、乙基、異丙基、正丙基、異丁基、正丁基、叔丁基、仲丁基、異戊基、環丙基、環戊基、環己基。 The above-mentioned alkyl group includes alkyl groups having 1 to 30 carbon atoms, preferably 1 to 10 carbon atoms, preferably 1 to 4 carbon atoms. The alkyl group may be branched or linear, or cyclic, and may be interrupted by one or more heteroatoms, preferably N, O, or S. Furthermore, the alkyl group may be substituted with one or more halogens or the above-mentioned substituents regarding aryl groups. Similarly, for alkyl groups, it is possible to carry one or more aryl groups, all of which are suitable for this purpose, alkyl groups are particularly preferably selected from methyl, ethyl, isopropyl, n-propyl, Isobutyl, n-butyl, tert-butyl, sec-butyl, isopentyl, cyclopropyl, cyclopentyl, cyclohexyl.
上述醯基是以單鍵連接至CO基團的,如本文所用的烷基。 The above-mentioned acyl group is connected to the CO group with a single bond, such as an alkyl group as used herein.
上述烷氧基是以單鍵與氧直接相連的,如本文所用的烷基。 The above-mentioned alkoxy group is directly connected to oxygen by a single bond, as used herein an alkyl group.
上述雜芳基團被理解為與芳族、C3-C8環基相關,並且還包含一個氧或硫原子或1-4個氮原子或一個氧或硫原子與最多兩個氮原子的組合,和他們的取代的以及苯並和吡啶並稠和的衍生物,例如,經由其中一個成環碳原子相連,所述雜芳基團可被一個或多個提到的關於芳基的取代基所取代。 The above heteroaryl group is understood to be related to an aromatic, C 3 -C 8 cyclic group, and also contains an oxygen or sulfur atom or 1-4 nitrogen atoms or a combination of an oxygen or sulfur atom and up to two nitrogen atoms , And their substituted and benzo and pyrido fused derivatives, for example, through one of the ring-forming carbon atoms, the heteroaryl group may be substituted by one or more of the substituents mentioned for aryl Replaced by.
在某些實施方案中,雜芳基可為攜帶以上獨立的含有0、1或2個取代基的五、六元芳族雜環體系。雜芳基的典型實例包括但不限於未取代的呋喃、苯並呋喃、噻吩、苯並噻吩、吡咯、吡啶、吲哚、唑、苯並唑、異唑、苯並異唑、噻唑、苯並噻唑、異噻唑、咪唑、苯並咪唑、吡唑、吲唑、四唑、喹啉、異喹啉、噠嗪、嘧啶、嘌呤和吡嗪、呋喃、1,2,3-二唑、1,2,3-噻二唑、1,2,4-噻二唑、三唑、苯並三唑、喋啶、苯並唑、二唑、苯並吡唑、喹嗪、噌啉、酞嗪、喹唑和喹喔啉及其單-或二-取代的衍生物。在某些實施方案中,取代基為鹵代、羥基、氰基、O-C1~6烷基、C1~6烷基、羥基C1~6烷基和氨基-C1~6烷基。 In certain embodiments, the heteroaryl group may be a five- or six-membered aromatic heterocyclic system carrying the above independent groups containing 0, 1, or 2 substituents. Typical examples of heteroaryl groups include, but are not limited to, unsubstituted furan, benzofuran, thiophene, benzothiophene, pyrrole, pyridine, indole, azole, benzoxazole, isoxazole, benzisoazole, thiazole, benzo Thiazole, isothiazole, imidazole, benzimidazole, pyrazole, indazole, tetrazole, quinoline, isoquinoline, pyridazine, pyrimidine, purine and pyrazine, furan, 1,2,3-diazole, 1, 2,3-thiadiazole, 1,2,4-thiadiazole, triazole, benzotriazole, pyridine, benzoxazole, diazole, benzopyrazole, quinazine, cinnoline, phthalazine, Quinazol and quinoxaline and their mono- or di-substituted derivatives. In certain embodiments, the substituents are halo, hydroxy, cyano, OC 1-6 alkyl, C 1-6 alkyl, hydroxy C 1-6 alkyl, and amino-C 1-6 alkyl.
如下所示的具體實例,包括但不限於以下結構:
上述配合物的製備方法,包括如下步驟:如下所示,咔唑類衍生物S1經溴代反應得到底物S2,S2與聯硼酸頻哪醇酯反應得到相應的頻哪醇酯衍生物S3,S3與吡啶類衍生物S4經Suzuki反應得到S5,S5與吡啶類衍生物S6經Suzuki反應得到S7,S7脫甲基後得到相應的配體S8,S8與K2PtCl4反應即得到目標產物P。 The preparation method of the above complex includes the following steps: as shown below, the carbazole derivative S1 is brominated to obtain the substrate S2 , and S2 is reacted with biboronic acid pinacol ester to obtain the corresponding pinacol ester derivative S3 , S3 and S4 pyridine derivatives via Suzuki reaction S5, S5 and S6 pyridine derivatives via Suzuki reaction S7, S7 after demethylation to yield the corresponding ligand S8, S8 K 2 PtCl 4 to obtain the target product is reacted with P .
該N^N^N^O四齒鉑(II)配合物可以用於OLED發光器件中,在發光層中起光子發射作用的磷光摻雜材料。所述四齒鉑(II)配合物的摻雜量為1%-12%。優選4%-8%。 The N^N^N^O tetradentate platinum (II) complex can be used in an OLED light emitting device, a phosphorescent doped material that functions as a photon emission in the light emitting layer. The doping amount of the tetradentate platinum (II) complex is 1%-12%. Preferably 4%-8%.
採用具有上述結構的鉑(II)配合物,可製造熱沉積和溶液處理的OLED器件。 Using the platinum (II) complex having the above structure, an OLED device of thermal deposition and solution treatment can be manufactured.
包括含有一種或多種配合物的有機發光器件。 Includes organic light-emitting devices containing one or more complexes.
其中通過熱沉積在該器件中以層形式施加該配合物。 The complex is applied as a layer in the device by thermal deposition.
其中通過旋塗在該器件中以層形式施加該配合物。 The complex is applied as a layer in the device by spin coating.
其中通過噴墨列印在該器件中以層形式施加該配合物。 The complex is applied in the form of a layer in the device by inkjet printing.
上述有機發光器件,在施加電流時該器件發射為橙紅色。 In the above organic light-emitting device, the device emits orange-red when current is applied.
本發明中的鉑(II)配合物具有高螢光量子效率,良好的熱穩定性及低淬滅常數,可以製造高發光效率、低滾降的橙紅色光OLED器件。 The platinum (II) complex in the invention has high fluorescence quantum efficiency, good thermal stability and low quenching constant, and can produce orange-red light OLED devices with high luminous efficiency and low roll-off.
10:玻璃基板 10: Glass substrate
20:透明陽極氧化銦錫(ITO) 20: Transparent indium tin oxide (ITO)
30:空穴傳輸層 30: hole transport layer
40:發光層 40: light emitting layer
50:電子傳輸層 50: electron transport layer
60:電子注入層 60: electron injection layer
70:陰極 70: cathode
圖1為本發明有機電致發光器件結構示意圖。 FIG. 1 is a schematic structural diagram of an organic electroluminescent device of the present invention.
下面結合實施例對本發明做進一步的詳細說明。 The present invention will be further described in detail below in conjunction with examples.
實施例1: Example 1:
合成路線: synthetic route:
化合物2的合成:取6.50g(20.0mmol)化合物1,聯硼酸頻哪醇酯12.70g(2.5eq.,50.0mmol),碳酸鉀5.18g(2.5eq.,50.0mmol)和Pd(dppf)Cl2 292mg(0.02eq.,0.4mmol),加入到三頸燒瓶中,抽真空通入氮氣置換多次,然後注入乙腈二氧六環150mL,加熱至85℃。在氮氣保護下反應12hr後,冷卻至室溫,旋蒸除去溶劑,再加入適量水和乙酸乙酯萃取,收集有機相,無水硫酸鎂乾燥後加入適量矽膠,旋蒸除去溶劑,使用正己烷/乙酸乙酯體系柱層析,得到白色固體7.12g,產率85%,純度99.0%。 Synthesis of Compound 2 : 6.50 g (20.0 mmol) of Compound 1 , 12.70 g (2.5 eq., 50.0 mmol) of pinacol biborate, 5.18 g (2.5 eq., 50.0 mmol) of potassium carbonate and Pd(dppf)Cl 2 292 mg (0.02 eq., 0.4 mmol) was added to a three-necked flask, and the vacuum was replaced with nitrogen for several times, and then 150 mL of acetonitrile dioxane was injected and heated to 85°C. After reacting under nitrogen for 12 hr, cool to room temperature, spin-evaporate to remove the solvent, then add appropriate amount of water and ethyl acetate for extraction, collect the organic phase, dry the anhydrous magnesium sulfate, add appropriate amount of silica gel, spin-evaporate to remove the solvent, use n-hexane/ Column chromatography with ethyl acetate system gave 7.12g white solid with 85% yield and 99.0% purity.
化合物3的合成:取11.85g(50.0mmol)化合物2,6-二溴吡啶,2-甲氧基苯硼酸7.60g(1.0eq.,50.0mmol),碳酸鉀6.48g(1.25eq.,62.5mmol) 和Pd(OAc)2 224mg(0.02eq.,1mmol),PPh3 1.31g(0.1eq.,5mmol)加入到三頸燒瓶中,抽真空通入氮氣置換多次,然後注入乙腈150mL,甲醇50mL,加熱至60℃。在氮氣保護下反應12hr後,冷卻至室溫,旋蒸除去溶劑,再加入適量水和乙酸乙酯萃取,收集有機相,無水硫酸鎂乾燥後加入適量矽膠,旋蒸除去溶劑,使用正己烷/乙酸乙酯體系柱層析,得到白色固體9.90g,產率75%,純度99.5%。 Synthesis of Compound 3 : 11.85g (50.0mmol) of compound 2,6-dibromopyridine, 2-methoxybenzeneboronic acid 7.60g (1.0eq., 50.0mmol), potassium carbonate 6.48g (1.25eq., 62.5mmol) ) And Pd(OAc) 2 224 mg (0.02 eq., 1 mmol), PPh 3 1.31 g (0.1 eq., 5 mmol) were added to a three-necked flask, vacuum was replaced with nitrogen for multiple times, then 150 mL of acetonitrile and 50 mL of methanol were injected , Heated to 60 ℃. After reacting under nitrogen for 12 hr, cool to room temperature, spin-evaporate to remove solvent, then add appropriate amount of water and ethyl acetate for extraction, collect organic phase, dry anhydrous magnesium sulfate, add appropriate amount of silica gel, spin-evaporate to remove solvent, use n-hexane/ Column chromatography with ethyl acetate system gave 9.90 g of white solid with 75% yield and 99.5% purity.
化合物4的合成:取6.29g(15.0mmol)化合物2,化合物3 3.96g(1.0eq.,15.0mmol),,碳酸鉀3.45g(1.25eq.,25.0mmol)和Pd(PPh3)4 347mg(0.02eq.,0.3mmol),加入到三頸燒瓶中,抽真空通入氮氣置換多次,然後注入乙腈100mL和50mL甲醇,加熱至60℃。在氮氣保護下反應12hr後,冷卻至室溫,旋蒸除去溶劑,再加入適量水和乙酸乙酯萃取,收集有機相,無水硫酸鎂乾燥後加入適量矽膠,旋蒸除去溶劑,使用正己烷/乙酸乙酯體系柱層析,得到白色固體4.28g,產率60%,純度99.5%。 Synthesis of compound 4 : Take 6.29 g (15.0 mmol) of compound 2 , compound 3 3.96 g (1.0 eq., 15.0 mmol), potassium carbonate 3.45 g (1.25 eq., 25.0 mmol) and Pd(PPh 3 ) 4 347 mg ( 0.02eq., 0.3mmol), added to a three-necked flask, evacuated and replaced with nitrogen for multiple times, and then injected 100mL and 50mL of acetonitrile methanol, heated to 60 ℃. After reacting under nitrogen for 12 hr, cool to room temperature, spin-evaporate to remove solvent, then add appropriate amount of water and ethyl acetate for extraction, collect organic phase, dry anhydrous magnesium sulfate, add appropriate amount of silica gel, spin-evaporate to remove solvent, use n-hexane/ Column chromatography with ethyl acetate system gave 4.28g white solid with 60% yield and 99.5% purity.
化合物5的合成:取3.81g(8.0mmol)化合物4,2-溴吡啶1.37g(1.1eq.,8.8mmol),碳酸鉀1.38g(1.25eq.,10.0mmol)和Pd(PPh3)4 185mg(0.02eq.,0.16mmol),加入到三頸燒瓶中,抽真空通入氮氣置換多次,然後注入乙腈60mL和30mL甲醇,加熱至60℃。在氮氣保護下反應12hr後,冷卻至室溫,旋蒸除去溶劑,再加入適量水和乙酸乙酯萃取,收集有機相,無水硫酸鎂乾燥後加入適量矽膠,旋蒸除去溶劑,使用正己烷/乙酸乙酯體系柱層析,得到白色固體3.07g,產率90%,純度99.9%。 Synthesis of compound 5 : Take 3.81 g (8.0 mmol) of compound 4 , 2- bromopyridine 1.37 g (1.1 eq., 8.8 mmol), potassium carbonate 1.38 g (1.25 eq., 10.0 mmol) and Pd(PPh 3 ) 4 185 mg (0.02eq., 0.16mmol), added to a three-necked flask, evacuated with nitrogen to replace multiple times, and then injected 60mL and 30mL of acetonitrile methanol, heated to 60 ℃. After reacting under nitrogen for 12 hr, cool to room temperature, spin-evaporate to remove solvent, then add appropriate amount of water and ethyl acetate for extraction, collect organic phase, dry anhydrous magnesium sulfate, add appropriate amount of silica gel, spin-evaporate to remove solvent, use n-hexane/ Column chromatography with ethyl acetate system gave 3.07g of white solid with 90% yield and 99.9% purity.
化合物6的合成:取2.14g(4.0mmol)化合物5,吡啶鹽酸鹽30g(PyHCl),加入到三頸燒瓶中,抽真空通入氮氣置換多次,在氮氣保護下 加熱至190℃,反應4hr後,冷卻至室溫,,再加入適量水和乙酸乙酯萃取,收集有機相,無水硫酸鎂乾燥後加入適量矽膠,旋蒸除去溶劑,使用正己烷/乙酸乙酯體系柱層析,得到白色固體1.32g,產率80%,純度99.9%。質譜(ESI-)([M-H]-)C28H18N3O理論值:412.15;實測值:412.13。 Synthesis of Compound 6 : Take 2.14g (4.0mmol) of Compound 5 and 30g of pyridine hydrochloride (PyHCl), add it to a three-necked flask, evacuate and introduce nitrogen for multiple replacements, heat to 190°C under the protection of nitrogen, and react After 4hr, cool to room temperature, then add appropriate amount of water and ethyl acetate for extraction, collect the organic phase, dry anhydrous magnesium sulfate, add appropriate amount of silica gel, spin-evaporate to remove the solvent, and use n-hexane/ethyl acetate system column chromatography to obtain White solid 1.32g, yield 80%, purity 99.9%. Mass spectrometry (ESI - )([MH] - ) C 28 H 18 N 3 O theoretical value: 412.15; found value: 412.13.
化合物P1的合成:取826mg(2.0mmol)化合物5和328mg無水醋酸鈉(2.0eq.,4.0mmol)溶於25mL DMSO中,攪拌,加熱至80℃,然後加入四氯鉑酸鉀830mg(1.0eq.,2.0mmol),抽真空通入氮氣置換數次,升溫到120℃反應5hr。反應結束後,趁熱加入100ml水,過濾,收集固體,用適量水和甲醇洗滌,將得到的固體用甲苯重結晶,然後真空昇華得到深紅色固體788mg,總產率65%,純度99.9%。質譜(ESI-)([M-H]-)C28H16N3OPt理論值:605.10;實測值:605.08。 Synthesis of Compound P1 : Take 826 mg (2.0 mmol) of Compound 5 and 328 mg of anhydrous sodium acetate (2.0 eq., 4.0 mmol) in 25 mL of DMSO, stir and heat to 80°C, then add 830 mg (1.0 eq) of potassium tetrachloroplatinate ., 2.0 mmol), replaced with nitrogen by evacuating several times, warming to 120 ℃ for 5hr. After the reaction was completed, 100 ml of water was added while hot, filtered, and the solid was collected, washed with an appropriate amount of water and methanol, and the obtained solid was recrystallized with toluene, and then sublimated in vacuo to obtain 788 mg of a dark red solid, with a total yield of 65% and a purity of 99.9%. Mass spectrum (ESI -) ([MH] -) C 28 H 16 N 3 OPt Calculated: 605.10; Found: 605.08.
實施例2: Example 2:
合成路線: synthetic route:
化合物7的合成:取16.72g咔唑(0.10mol)和655mg無水三氯化鋁(5mmol)於三頸燒瓶中,抽真空通入氮氣置換多次,然後滴加氯代叔丁烷27.77g(3.0eq.,0.30mmol)和乾燥的二氯甲烷250mL,在氮氣保護下攪拌反應12hr後,再加入適量水萃取,收集有機相,旋蒸除去溶劑,將得到的固體使用乙醇重結晶,得到白色固體23.20g,產率83%,純度99.5%。 Synthesis of Compound 7 : Take 16.72g of carbazole (0.10mol) and 655mg of anhydrous aluminum trichloride (5mmol) in a three-necked flask, evacuate and introduce nitrogen for multiple replacements, then add 27.77g of chloro-tert-butane dropwise ( 3.0eq., 0.30mmol) and dry dichloromethane 250mL, after stirring the reaction under nitrogen protection for 12hr, then add an appropriate amount of water for extraction, collect the organic phase, remove the solvent by rotary evaporation, and recrystallize the resulting solid using ethanol to obtain white Solid 23.20g, yield 83%, purity 99.5%.
化合物8的合成:取13.97g(50.0mmol)化合物7,溶於750mL醋酸中,然後滴入液溴19.98g(2.5eq.,125.0mmol),遮光反應。室溫攪拌約4hr後,旋蒸除去溶劑,再加入適量水和亞硫酸氫鈉溶液洗滌,乙酸乙酯萃取,收集有機相,無水硫酸鎂乾燥後加入適量矽膠,旋蒸除去溶劑,使用正己烷/乙酸乙酯體系柱層析,得到白色固體20.77g,產率95%,純度99.9%。 Synthesis of compound 8 : Take 13.97 g (50.0 mmol) of compound 7 and dissolve it in 750 mL of acetic acid, then drop into liquid bromine 19.98 g (2.5 eq., 125.0 mmol), and shield the reaction. After stirring at room temperature for about 4 hr, the solvent was removed by rotary evaporation, and then appropriate amount of water and sodium bisulfite solution were added for washing, ethyl acetate extraction, and the organic phase was collected. After drying over anhydrous magnesium sulfate, an appropriate amount of silica gel was added, and the appropriate amount of silicone was added to the rotary evaporation to remove the solvent. /Ethyl acetate system column chromatography to obtain 20.77g white solid, yield 95%, purity 99.9%.
化合物9的合成:取10.93g(25.0mmol)化合物8,聯硼酸頻哪醇酯15.88g(2.5eq.,62.5mmol),碳酸鉀8.64g(2.5eq.,62.5mmol)和Pd(dppf)Cl2 366mg(0.02eq.,0.5mmol),加入到三頸燒瓶中,抽真空通入氮氣置換多次,然後注入二氧六環300mL,加熱至85℃。在氮氣保護下反應12hr後,冷卻至室溫,旋蒸除去溶劑,再加入適量水和乙酸乙酯萃取,收集有機相,無水硫酸鎂乾燥後加入適量矽膠,旋蒸除去溶劑,使用正己烷/乙酸乙酯體系柱層析,得到白色固體9.56g,產率72%,純度99.9%。 Synthesis of Compound 9 : Take 10.93g (25.0mmol) of Compound 8 , 15.88g (2.5eq., 62.5mmol) of pinacol biborate, 8.64g (2.5eq., 62.5mmol) of potassium carbonate and Pd(dppf)Cl 2 366 mg (0.02 eq., 0.5 mmol) was added to the three-necked flask, and the vacuum was replaced with nitrogen gas for many times, and then 300 mL of dioxane was injected, and heated to 85°C. After reacting under nitrogen for 12 hr, cool to room temperature, spin-evaporate to remove solvent, then add appropriate amount of water and ethyl acetate for extraction, collect organic phase, dry anhydrous magnesium sulfate, add appropriate amount of silica gel, spin-evaporate to remove solvent, use n-hexane/ Column chromatography with ethyl acetate system gave 9.56 g of white solid with 72% yield and 99.9% purity.
化合物10的合成:取7.97g(15.0mmol)化合物9,化合物3 3.96g(1.0eq.,15.0mmol),,碳酸鉀3.45g(1.25eq.,25.0mmol)和Pd(PPh3)4 347mg(0.02eq.,0.3mmol),加入到三頸燒瓶中,抽真空通入氮氣置換多次,然後注入乙腈100mL和50mL甲醇,加熱至60℃。在氮氣保護下反應12hr後,冷卻至室溫,旋蒸除去溶劑,再加入適量水和乙酸乙酯萃取,收集 有機相,無水硫酸鎂乾燥後加入適量矽膠,旋蒸除去溶劑,使用正己烷/乙酸乙酯體系柱層析,得到白色固體5.74g,產率65%,純度99.9%。 Synthesis of compound 10 : Take 7.97 g (15.0 mmol) of compound 9 , compound 3 3.96 g (1.0 eq., 15.0 mmol), potassium carbonate 3.45 g (1.25 eq., 25.0 mmol) and Pd (PPh 3 ) 4 347 mg ( 0.02eq., 0.3mmol), added to a three-necked flask, evacuated and replaced with nitrogen for multiple times, and then injected 100mL and 50mL of acetonitrile methanol, heated to 60 ℃. After reacting under nitrogen for 12 hr, cool to room temperature, spin-evaporate to remove solvent, then add appropriate amount of water and ethyl acetate for extraction, collect organic phase, dry anhydrous magnesium sulfate, add appropriate amount of silica gel, spin-evaporate to remove solvent, use n-hexane/ Column chromatography with ethyl acetate system yielded 5.74g of white solid in 65% yield and 99.9% purity.
化合物11的合成:取4.71g(8.0mmol)化合物10,2-溴吡啶1.37g(1.1eq.,8.8mmol),碳酸鉀1.38g(1.25eq.,10.0mmol)和Pd(PPh3)4 185mg(0.02eq.,0.16mmol),加入到三頸燒瓶中,抽真空通入氮氣置換多次,然後注入乙腈60mL和30mL甲醇,加熱至60℃。在氮氣保護下反應12hr後,冷卻至室溫,旋蒸除去溶劑,再加入適量水和乙酸乙酯萃取,收集有機相,無水硫酸鎂乾燥後加入適量矽膠,旋蒸除去溶劑,使用正己烷/乙酸乙酯體系柱層析,得到白色固體3.67g,產率85%,純度99.9%。
Synthesis of compound 11 : Take 4.71 g (8.0 mmol) of
化合物12的合成:取2.16g(4.0mmol)化合物11,吡啶鹽酸鹽30g(PyHCl),加入到三頸燒瓶中,抽真空通入氮氣置換多次,在氮氣保護下加熱至190℃,反應4hr後,冷卻至室溫,,再加入適量水和乙酸乙酯萃取,收集有機相,無水硫酸鎂乾燥後加入適量矽膠,旋蒸除去溶劑,使用正己烷/乙酸乙酯體系柱層析,得到白色固體1.79g,產率85%,純度99.9%。質譜(ESI-)([M-H]-)C36H34N3O理論值:524.27;實測值:524.24。 Synthesis of Compound 12 : Take 2.16g (4.0mmol) of Compound 11 and 30g of pyridine hydrochloride (PyHCl), add it to a three-necked flask, and evacuate with nitrogen for multiple replacements, heat to 190°C under the protection of nitrogen, and react After 4hr, cool to room temperature, then add appropriate amount of water and ethyl acetate for extraction, collect the organic phase, dry anhydrous magnesium sulfate, add appropriate amount of silica gel, spin-evaporate to remove the solvent, and use n-hexane/ethyl acetate system column chromatography to obtain White solid 1.79g, yield 85%, purity 99.9%. Mass spectrum (ESI -) ([MH] -) C 36 H 34 N 3 O Calculated: 524.27; Found: 524.24.
化合物P2的合成:取1.06g(2.0mmol)化合物5和328mg無水醋酸鈉(2.0eq.,4.0mmol)溶於25mL DMSO中,攪拌,加熱至80℃,然後加入四氯鉑酸鉀830mg(1.0eq.,2.0mmol),抽真空通入氮氣置換數次,升溫到120℃反應5hr。反應結束後,趁熱加入100ml水,過濾,收集固體,用適量水和甲醇洗滌,將得到的固體用甲苯重結晶,然後真空昇華得到深紅色固體1.01g,總產率70%,99.9%。質譜(ESI-)([M-H]-)C36H33N3OPt理論值:717.23;實測值:717.20。 Synthesis of Compound P2 : Dissolve 1.06g (2.0mmol) of Compound 5 and 328mg of anhydrous sodium acetate (2.0eq., 4.0mmol) in 25mL of DMSO, stir and heat to 80°C, then add 830mg of potassium tetrachloroplatinate (1.0 eq., 2.0mmol), nitrogen was replaced by evacuation several times, the temperature was raised to 120 ℃ for 5hr. After the reaction was completed, 100 ml of water was added while hot, filtered, the solid was collected, washed with an appropriate amount of water and methanol, and the obtained solid was recrystallized with toluene, and then sublimated in vacuo to obtain a deep red solid 1.01 g, with a total yield of 70% and 99.9%. Mass spectrometry (ESI - )([MH] - ) C 36 H 33 N 3 OPt theoretical value: 717.23; found value: 717.20.
實施例3: Example 3:
合成路線: synthetic route:
化合物14的合成:取7.97g(15.0mmol)化合物9,化合物13 7.63g(1.0eq.,15.0mmol),,碳酸鉀3.45g(1.25eq.,25.0mmol)和Pd(PPh3)4 347mg(0.02eq.,0.3mmol),加入到三頸燒瓶中,抽真空通入氮氣置換多次,然後注入乙腈100mL和50mL甲醇,加熱至60℃。在氮氣保護下反應12hr後,冷卻至室溫,旋蒸除去溶劑,再加入適量水和乙酸乙酯萃取,收集有機相,無水硫酸鎂乾燥後加入適量矽膠,旋蒸除去溶劑,使用正己烷/乙酸乙酯體系柱層析,得到白色固體7.50g,產率60%,純度99.5%。 Synthesis of compound 14 : Take 7.97 g (15.0 mmol) of compound 9 , compound 13 7.63 g (1.0 eq., 15.0 mmol), potassium carbonate 3.45 g (1.25 eq., 25.0 mmol) and Pd(PPh 3 ) 4 347 mg ( 0.02eq., 0.3mmol), added to a three-necked flask, evacuated and replaced with nitrogen for multiple times, and then injected 100mL and 50mL of acetonitrile methanol, heated to 60 ℃. After reacting under nitrogen for 12 hr, cool to room temperature, spin-evaporate to remove solvent, then add appropriate amount of water and ethyl acetate for extraction, collect organic phase, dry anhydrous magnesium sulfate, add appropriate amount of silica gel, spin-evaporate to remove solvent, use n-hexane/ Column chromatography with ethyl acetate system gave 7.50 g of white solid with 60% yield and 99.5% purity.
化合物15的合成:取6.66g(8.0mmol)化合物14,2-溴吡啶1.37g(1.1eq.,8.8mmol),碳酸鉀1.38g(1.25eq.,10.0mmol)和Pd(PPh3)4 185mg(0.02eq.,0.16mmol),加入到三頸燒瓶中,抽真空通入氮氣置換多次,然後注入乙腈60mL和30mL甲醇,加熱至60℃。在氮氣保護下反應12hr後,冷卻至室溫,旋蒸除去溶劑,再加入適量水和乙酸乙酯萃取,收集有機相,無水硫酸鎂乾燥後加入適量矽膠,旋蒸除去溶劑,使用正己烷/乙酸乙酯體系柱層析,得到白色固體6.27g,產率80%,純度99.9%。 Synthesis of compound 15 : Take 6.66 g (8.0 mmol) of compound 14 , 2-bromopyridine 1.37 g (1.1 eq., 8.8 mmol), potassium carbonate 1.38 g (1.25 eq., 10.0 mmol) and Pd(PPh 3 ) 4 185 mg (0.02eq., 0.16mmol), added to a three-necked flask, evacuated with nitrogen to replace multiple times, and then injected 60mL and 30mL of acetonitrile methanol, heated to 60 ℃. After reacting under nitrogen for 12 hr, cool to room temperature, spin-evaporate to remove solvent, then add appropriate amount of water and ethyl acetate for extraction, collect organic phase, dry anhydrous magnesium sulfate, add appropriate amount of silica gel, spin-evaporate to remove solvent, use n-hexane/ Column chromatography with ethyl acetate system gave 6.27 g of white solid with 80% yield and 99.9% purity.
化合物16的合成:取3.14g(4.0mmol)化合物15,吡啶鹽酸鹽30g(PyHCl),加入到三頸燒瓶中,抽真空通入氮氣置換多次,在氮氣保護下加熱至190℃,反應4hr後,冷卻至室溫,,再加入適量水和乙酸乙酯萃取,收集有機相,無水硫酸鎂乾燥後加入適量矽膠,旋蒸除去溶劑,使用正己烷/乙酸乙酯體系柱層析,得到白色固體2.77g,產率90%,純度99.9%。質譜(ESI-)([M-H]-)C54H62N3O理論值:768.50;實測值:768.47。 Synthesis of compound 16 : Take 3.14g (4.0mmol) of compound 15 and pyridine hydrochloride 30g (PyHCl), add to a three-necked flask, evacuate and introduce nitrogen for multiple replacements, heat to 190°C under nitrogen, react After 4hr, cool to room temperature, then add appropriate amount of water and ethyl acetate for extraction, collect the organic phase, dry anhydrous magnesium sulfate, add appropriate amount of silica gel, spin-evaporate to remove the solvent, and use n-hexane/ethyl acetate system column chromatography to obtain White solid 2.77g, yield 90%, purity 99.9%. Mass spectrum (ESI -) ([MH] -) C 54 H 62 N 3 O Calculated: 768.50; Found: 768.47.
化合物P105的合成:取1.54g(2.0mmol)化合物16和328mg無水醋酸鈉(2.0eq.,4.0mmol)溶於25mL DMSO中,攪拌,加熱至80℃,然 後加入四氯鉑酸鉀830mg(1.0eq.,2.0mmol),抽真空通入氮氣置換數次,升溫到120℃反應5hr。反應結束後,趁熱加入100ml水,過濾,收集固體,用適量水和甲醇洗滌,將得到的固體用甲苯重結晶,然後真空昇華得到深紅色固體1.25g,總產率65%,純度99.9%。質譜(ESI-)([M-H]-)C54H60N3OPt理論值:961.44;實測值:961.42。 Synthesis of Compound P105 : Take 1.54 g (2.0 mmol) of Compound 16 and 328 mg of anhydrous sodium acetate (2.0 eq., 4.0 mmol) in 25 mL of DMSO, stir and heat to 80°C, then add 830 mg of potassium tetrachloroplatinate (1.0 eq., 2.0mmol), nitrogen was replaced by evacuation several times, the temperature was raised to 120 ℃ for 5hr. After the reaction, add 100ml of water while hot, filter, collect the solid, wash with appropriate amount of water and methanol, recrystallize the obtained solid with toluene, and then vacuum sublimate to obtain a dark red solid 1.25g, total yield 65%, purity 99.9% . Mass spectrum (ESI -) ([MH] -) C 54 H 60 N 3 OPt Calculated: 961.44; Found: 961.42.
實施例的Pt(II)配合物,在二氯甲烷溶液溶液中呈現出明顯的橙紅光發射,如下表所示:
下面是本發明化合物的應用實例。 The following are application examples of the compounds of the present invention.
器件製備方式: Device preparation method:
器件的基本結構模型為:ITO/HTL-1(60nm)/EML-1:Pt(II)(40nm)/ETL-1(30nm)/LiF(1nm)/Al(80nm)。 The basic structure model of the device is: ITO/HTL-1 (60nm)/EML-1: Pt(II) (40nm)/ETL-1 (30nm)/LiF (1nm)/Al (80nm).
依次使用丙酮、乙醇和蒸餾水對透明陽極氧化銦錫(ITO)20(10Ω/sq)玻璃基板10進行超聲清洗,再用氧氣等離子處理5分鐘。
The transparent indium tin oxide (ITO) 20 (10Ω/sq)
然後將ITO襯底安裝在真空氣相蒸鍍設備的襯底固定器上。在蒸鍍設備中,控制體系壓力在10-6torr.。 Then, the ITO substrate is mounted on the substrate holder of the vacuum vapor deposition equipment. In the evaporation equipment, control the system pressure at 10 -6 torr.
此後,向ITO襯底上蒸發厚度為60nm的空穴傳輸層30材料HTL-1。
Thereafter, the
然後蒸發厚度為40nm的發光層40材料EML-1,其中摻雜不同品質分數的鉑(II)配合物摻雜劑。
Then, the material EML-1 of the light-emitting
然後蒸發厚度為30nm的電子傳輸層50材料ETL-1。
The
然後蒸發厚度為1nm的LiF為電子注入層60。
Then, LiF with a thickness of 1 nm is evaporated as the
最後蒸發厚度為80nm的Al作為陰極70並完成器件封裝。見圖1所示。
Finally, Al with a thickness of 80 nm is evaporated as the
測試器件的結構和製作方法完全相同,區別在於依次使用有機金屬配合物Pt0、Pt1、Pt2、Pt105作為發光層中的摻雜劑和摻雜濃度。其中,Pt0為經典的O^N^N^O類紅光材料。 The structure and manufacturing method of the test device are identical, the difference is that the organometallic complexes Pt0, Pt1, Pt2, and Pt105 are used in sequence as the dopant and doping concentration in the light-emitting layer. Among them, Pt0 is a classic O^N^N^O type red light material.
器件對比結果下表所示:
在四齒鉑(II)配合物摻雜濃度分別為4wt%,8wt%,12wt%條件下,以上述ITO/HTL-1(60nm)/EML-1:Pt(II)(40nm)/ETL-1(30nm)/LiF(1nm)/Al(80nm)器件基本結構製備器件。以基於Pt0的器件性能為參考,四齒鉑(II)配合物Pt1,Pt2,Pt105的器件在啟動電壓Von相比Pt0的器件均有不同程度的降低,尤其是基於Pt105的器件其啟動電壓降至3.0V。同時,在1000cd/A條件下,基於Pt1,Pt2,Pt105的器件在電流效率(CE),功率效率(PE)和外量子效率(EQE)相對於基於Pt-0的器件均有不同程度的提升,尤其是Pt105,在電流效率(CE),功率效率(PE)和外量子效率(EQE)上提升較為明顯。在四齒鉑(II)配合物摻雜濃度增加時,Pt0,Pt1的效率提升較小甚至效率有一定程度的下降,但是Pt105有較好的效率提升,其電流效率由73.5cd/A提升至78.5cd/A,功率效率由67.8 lm/W提升至78.5 lm/W,外量子效率由17.8%提升至18.7%。Pt105相對於Pt0,Pt1,Pt2有較大的位阻基團,能有效降低分子間的聚集作用,避免形成激基複合物,提高發光效率。同時,Pt1,Pt2相對於Pt0在性能上也有不同程度的提升。 Under the condition that the doping concentration of the tetradentate platinum(II) complex is 4wt%, 8wt%, and 12wt%, the above ITO/HTL-1(60nm)/EML-1: Pt(II)(40nm)/ETL- 1(30nm)/LiF(1nm)/Al(80nm) device basic structure to prepare device. Taking the performance of Pt0-based devices as a reference, the starting voltage V on of the four-tooth platinum (II) complexes Pt1, Pt2, and Pt105 devices is reduced to varying degrees compared to Pt0 devices, especially the starting voltage of Pt105-based devices. Down to 3.0V. At the same time, under the conditions of 1000cd/A, the current efficiency (CE), power efficiency (PE) and external quantum efficiency (EQE) of devices based on Pt1, Pt2 and Pt105 have different degrees of improvement compared with devices based on Pt-0 , Especially Pt105, the improvement in current efficiency (CE), power efficiency (PE) and external quantum efficiency (EQE) is more obvious. When the doping concentration of the tetradentate platinum (II) complex increases, the efficiency of Pt0 and Pt1 is small or even decreased to a certain extent, but Pt105 has a better efficiency, and its current efficiency is increased from 73.5cd/A to 78.5cd/A, power efficiency increased from 67.8 lm/W to 78.5 lm/W, external quantum efficiency increased from 17.8% to 18.7%. Compared with Pt0, Pt1 and Pt2, Pt105 has larger steric groups, which can effectively reduce the aggregation between molecules, avoid the formation of exciplex, and improve the luminous efficiency. At the same time, Pt1 and Pt2 have different levels of performance improvement over Pt0.
綜上所述,本發明所製備的有機電致發光器件的性能相對於基準器件具有較好的性能提升,所涉及的新型N^N^N^O四齒鉑(II)配合物金屬有機材料具有較大的應用價值。 In summary, the performance of the organic electroluminescent device prepared by the present invention has better performance than the reference device, and the new N^N^N^O tetradentate platinum (II) complex metal organic material is involved Has greater application value.
Claims (10)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711454918 | 2017-12-28 | ||
CN201711454918.3 | 2017-12-28 | ||
??201711454918.3 | 2017-12-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201930331A TW201930331A (en) | 2019-08-01 |
TWI695008B true TWI695008B (en) | 2020-06-01 |
Family
ID=67066602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW107147289A TWI695008B (en) | 2017-12-28 | 2018-12-26 | An organic electroluminescent device containing tetradentate platinum (ii) complex |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN109980111B (en) |
TW (1) | TWI695008B (en) |
WO (1) | WO2019128896A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110957431A (en) * | 2019-11-29 | 2020-04-03 | 香港大学深圳研究院 | Platinum complex-based organic light-emitting device suitable for wet preparation |
CN110993831A (en) * | 2019-11-29 | 2020-04-10 | 香港大学深圳研究院 | Wet preparation method of organic light-emitting device based on platinum complex |
CN113024606B (en) * | 2019-12-24 | 2023-04-18 | 广东阿格蕾雅光电材料有限公司 | O ^ C ^ N ^ N type tetradentate platinum (II) complex, preparation method and application thereof |
CN113698432B (en) * | 2020-05-21 | 2024-03-08 | 广东阿格蕾雅光电材料有限公司 | Preparation and application of tetradentate platinum (II) complex |
CN113801166B (en) * | 2020-06-16 | 2023-04-07 | 广东阿格蕾雅光电材料有限公司 | Tetradentate metal complex and application thereof |
CN114573639B (en) * | 2020-11-30 | 2023-12-12 | 广东阿格蕾雅光电材料有限公司 | Platinum complex of ONCN tetradentate ligand containing carbazole |
CN114644657B (en) * | 2020-12-21 | 2024-05-31 | 广东阿格蕾雅光电材料有限公司 | Bivalent platinum complex |
CN113683646B (en) * | 2021-09-18 | 2024-04-05 | 广西民族大学 | Platinum complex containing monocarborane metal, preparation method and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012162488A1 (en) * | 2011-05-26 | 2012-11-29 | Arizona Board Of Regents Acting For And On Behalf Of Arizona State University | Synthesis of platinum and palladium complexes as narrow-band phosphorescent emitters for full color displays |
US20160240800A1 (en) * | 2015-02-13 | 2016-08-18 | Universal Display Corporation | Organic electroluminescent materials and devices |
US20170040555A1 (en) * | 2015-08-04 | 2017-02-09 | Jian Li | Tetradentate Platinum (II) and Palladium (II) Complexes, Devices, and Uses Thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8877353B2 (en) * | 2010-07-21 | 2014-11-04 | Versitech Limited | Platinum (II) tetradentate ONCN complexes for organic light-emitting diode applications |
WO2012116231A2 (en) * | 2011-02-23 | 2012-08-30 | Universal Display Corporation | Novel tetradentate platinum complexes |
JP5967663B2 (en) * | 2011-09-08 | 2016-08-10 | 国立大学法人大阪大学 | Platinum complex |
CN104245714B (en) * | 2012-04-12 | 2017-09-26 | 港大科桥有限公司 | Platinum (II) complex compound applied for OLED |
JP6804823B2 (en) * | 2013-10-14 | 2020-12-23 | アリゾナ・ボード・オブ・リージェンツ・オン・ビハーフ・オブ・アリゾナ・ステイト・ユニバーシティーArizona Board of Regents on behalf of Arizona State University | Platinum complex and device |
CN105273712B (en) * | 2014-07-11 | 2017-07-25 | 广东阿格蕾雅光电材料有限公司 | Luminescent material for light emitting diode |
-
2018
- 2018-12-21 CN CN201811567622.7A patent/CN109980111B/en active Active
- 2018-12-23 WO PCT/CN2018/122966 patent/WO2019128896A1/en active Application Filing
- 2018-12-26 TW TW107147289A patent/TWI695008B/en active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012162488A1 (en) * | 2011-05-26 | 2012-11-29 | Arizona Board Of Regents Acting For And On Behalf Of Arizona State University | Synthesis of platinum and palladium complexes as narrow-band phosphorescent emitters for full color displays |
US20160240800A1 (en) * | 2015-02-13 | 2016-08-18 | Universal Display Corporation | Organic electroluminescent materials and devices |
US20170040555A1 (en) * | 2015-08-04 | 2017-02-09 | Jian Li | Tetradentate Platinum (II) and Palladium (II) Complexes, Devices, and Uses Thereof |
Also Published As
Publication number | Publication date |
---|---|
TW201930331A (en) | 2019-08-01 |
CN109980111B (en) | 2021-02-19 |
WO2019128896A1 (en) | 2019-07-04 |
CN109980111A (en) | 2019-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI695008B (en) | An organic electroluminescent device containing tetradentate platinum (ii) complex | |
TWI695007B (en) | A tetradentate platinum (ii) complex and application thereof | |
WO2019128895A1 (en) | Tetradentate platinum (ii) complex material based on oxazole, thiazole or imidazole and use | |
CN111377972B (en) | Binuclear tetradentate platinum (II) complex and application thereof | |
TWI774368B (en) | Preparation and application of a tetradentate platinum (ii) complex | |
WO2020134569A1 (en) | Preparation of n^n^c^o tetradentate platinum (ii) complex and uses thereof | |
KR102699343B1 (en) | O^C^N^N type 4-membered platinum(II) compound, its preparation method and its application | |
TWI774078B (en) | Preparation and application of a tetradentate platinum (ii) complex | |
JP7249061B2 (en) | Preparation and use of N^N^C^N-type tetradentate platinum(II) complex | |
TWI675036B (en) | Device containing organic metal complex luminescent material | |
TWI675035B (en) | Organic metal complex luminescent material |